세계의 방사선 독성 치료 시장 보고서(2025년)

Radiation Toxicity Treatment Global Market Report 2025

US $ 4,490 ￦ 6,272,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,065,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,859,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

방사선 독성 치료 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.4%의 성장률로 51억 2,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중 성장의 배경에는 맞춤형 의료 접근법의 부상, 예방 의료의 중요성, 외래 의료 서비스에 대한 수요 증가, 방사선 안전에 대한 세계 인식 제고 캠페인 증가, 암 치료 접근성 향상을 위한 정부 구상의 강화 등이 있습니다. 예측 기간의 주요 동향으로는 치료 계획에 인공지능의 통합, 영상 유도 방사선 치료의 주요 발전, 정위적 방사선 치료의 개발, 나노입자 약물전달 시스템의 혁신, 맞춤형 치료 솔루션을 위한 3D 프린팅의 활용 등을 들 수 있습니다.

암 발병률 증가는 방사선 독성 치료 시장의 성장을 촉진할 것으로 예측됩니다. 암은 통제할 수 없는 비정상적인 세포의 증식과 확산으로 특징지어지는 질병군을 말하며, 이 비정상적인 세포는 주변 조직을 침범하여 신체의 다른 부위로 전이될 수 있습니다. 생활습관의 변화, 환경오염, 유전적 소인, 조기 발견을 가능하게 하는 진단기술의 발전 등의 요인이 암 발생률 증가에 기여하고 있습니다. 방사선 독성 치료는 방사선 치료의 부작용을 관리하고, 환자의 회복을 돕고, 장기적인 피해를 줄이는 데 중요한 역할을 합니다. 예를 들어 2024년 8월 맥밀런 캔서 서포트가 발표한 보고서에 따르면 영국에서 300만 명 이상이 암과 함께 생활하고 있으며, 2025년까지 350만 명, 2030년까지 400만 명, 2040년까지 530만 명으로 늘어날 것으로 예측됩니다. 이처럼 암 발병률 증가는 방사선 독성 치료 시장의 확대에 박차를 가하고 있습니다.

방사선 독성 치료 시장의 기업은 치료의 정확성과 효과를 높이기 위해 특히 첨단 약물전달 시스템의 혁신에 집중하고 있습니다. 이러한 시스템은 환자의 순응도를 높이고, 부작용을 최소화하며, 궁극적으로 더 나은 치료 결과와 빠른 회복을 목표로 합니다. 약물전달 시스템은 약물이 적절한 용량으로 체내 표적 부위에 도달하도록 보장하여 불필요한 영향을 줄이면서 효능을 높입니다. 예를 들어 2023년 12월 미국 바이오 제약회사 코헬라스 바이오사이언스는 페그필그라스팀-cbqv의 새로운 체내 주사기인 UDENYCA ONBODY가 미국 FDA의 승인을 받았다고 발표했습니다. 이 장비는 발열성 호중구감소증으로 인한 감염 위험을 줄이기 위해 화학요법 다음 날에 사용됩니다. 이 주사기는 5분 만에 약물을 투여할 수 있으며, 안전성과 편의성을 높이기 위해 개폐 가능한 주사바늘을 갖추고 있습니다. 이번 승인을 통해 코헬러스는 화학요법의 부작용을 관리할 수 있는 보다 편리하고 사용자 친화적인 솔루션을 제공하고자 합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 방사선 독성 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 용도 산업의 분석
• 세계의 방사선 독성 치료 시장 : 성장률 분석
• 세계의 방사선 독성 치료 시장 실적 : 규모와 성장, 2019-2024
• 세계의 방사선 독성 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 방사선 독성 치료 TAM(Total Addressable Market)

제6장 시장 세분화

• 세계의 방사선 독성 치료 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 콜로니자극인자
• 요오드화칼륨
• 프러시안 블루
• DTPA(Diethylenetriamine Pentaacetic Acid)
• 기타 제품
• 세계의 방사선 독성 치료 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 급성 방사선 증후군
• 만성 방사선 증후군
• 세계의 방사선 독성 치료 시장 : 방사선 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 전리 방사선
• 비전리 방사선
• 세계의 방사선 독성 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 조사·학술기관
• 세계의 방사선 독성 치료 시장, 콜로니자극인자의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 과립구 콜로니자극인자(G-CSF)
• 과립구 마크로파지 콜로니자극인자(GM-CSF)
• 세계의 방사선 독성 치료 시장, 요오드화칼륨의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 경구 요오드화칼륨 정제
• 액체 요오드화칼륨 용액
• 세계의 방사선 독성 치료 시장, 프러시안 블루의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 프러시안 블루 캡슐
• 프러시안 블루 수지
• 세계의 방사선 독성 치료 시장, DTPA(Diethylenetriamine Pentaacetic Acid)(DTPA)의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• DTPA 주사(칼슘 및 아연 DTPA)
• 세계의 방사선 독성 치료 시장, 기타 제품의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Amifostine
• Sodium Bicarbonate
• Doxycycline
• 활성탄

제7장 지역별·국가별 분석

• 세계의 방사선 독성 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 방사선 독성 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 방사선 독성 치료 시장 : 경쟁 구도
• 방사선 독성 치료 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

• AstraZeneca PLC
• Novartis AG
• Amgen Inc.
• Varian Medical Systems
• Recipharm AB
• Elekta AB
• Lantheus Medical Imaging Inc.
• Ion Beam Applications SA
• Accuray Incorporated
• Coherus BioSciences Inc.
• Eckert & Ziegler Strahlen-und Medizintechnik AG
• Theragenics Corp.
• NorthStar Medical Radioisotopes LLC
• Fusion Pharmaceuticals Inc.
• Blue Earth Diagnostics Ltd.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 방사선 독성 치료 시장 2029 : 새로운 기회를 제공하는 국가
• 방사선 독성 치료 시장 2029 : 새로운 기회를 제공하는 부문
• 방사선 독성 치료 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁의 전략

제36장 부록

KSA

영문 목차

영문목차

Radiation toxicity treatment involves medical strategies aimed at alleviating and reducing the harmful effects of excessive radiation exposure. These treatments focus on managing symptoms such as fatigue, nausea, and skin damage, as well as more severe issues such as organ or bone marrow damage, with the goal of supporting recovery and minimizing long-term health risks.

Key products in the radiation toxicity treatment market include colony stimulating factors, potassium iodide, prussian blue, diethylenetriamine pentaacetic acid, and others. Colony stimulating factors are biological agents that stimulate the production of blood cells by activating bone marrow. These substances play a vital role in restoring blood cell levels in conditions that cause low blood counts, such as during medical treatments. They are used to treat conditions such as acute and chronic radiation syndrome, addressing both ionizing and non-ionizing radiation types. These products are utilized in hospitals, as well as research and academic institutions.

The radiation toxicity treatment market research report is one of a series of new reports from The Business Research Company that provides radiation toxicity treatment market statistics, including the radiation toxicity treatment industry's global market size, regional shares, competitors with a radiation toxicity treatment market share, detailed radiation toxicity treatment market segments, market trends and opportunities, and any further data you may need to thrive in the radiation toxicity treatment industry. This radiation toxicity treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiation toxicity treatment market size has grown strongly in recent years. It will grow from $3.74 billion in 2024 to $3.99 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historical period can be attributed to the increasing global prevalence of cancer, a rising demand for radiotherapy as a treatment option, the expansion of healthcare infrastructure and facilities, a higher incidence of radiation exposure, and an increased awareness of radiation toxicity.

The radiation toxicity treatment market size is expected to see strong growth in the next few years. It will grow to $5.12 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The expected growth in the forecast period is driven by the rise of personalized medicine approaches, a greater emphasis on preventive healthcare, a growing demand for outpatient care services, increased global awareness campaigns about radiation safety, and more government initiatives aimed at improving access to cancer care. Key trends in the forecast period include the integration of artificial intelligence in treatment planning, advancements in image-guided radiation therapy, the development of stereotactic body radiation therapy, innovations in nanoparticle drug delivery systems, and the use of 3D printing for customized treatment solutions.

The rising incidence of cancer is expected to drive the growth of the radiation toxicity treatment market. Cancer refers to a group of diseases marked by the uncontrolled growth and spread of abnormal cells that can invade nearby tissues and metastasize to other parts of the body. Factors such as lifestyle changes, environmental pollution, genetic predisposition, and advancements in diagnostic technologies, which enable earlier detection, contribute to the increasing cancer rates. Radiation toxicity treatment plays a crucial role in managing the side effects of radiation therapy, aiding patient recovery, and reducing long-term harm. For example, a report from Macmillan Cancer Support in August 2024 revealed that over 3 million people in the UK are living with cancer, a number expected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As such, the growing cancer prevalence is fueling the expansion of the radiation toxicity treatment market.

Companies in the radiation toxicity treatment market are focusing on innovations, particularly in advanced drug delivery systems, to enhance the precision and effectiveness of treatments. These systems aim to improve patient compliance, minimize side effects, and ultimately lead to better outcomes and quicker recovery. A drug delivery system ensures that medication reaches targeted areas of the body in the right dosage, enhancing efficacy while limiting unwanted effects. For instance, in December 2023, Coherus BioSciences, a US-based biopharmaceutical firm, announced the U.S. FDA's approval of UDENYCA ONBODY, a new on-body injector for pegfilgrastim-cbqv. This device is used the day after chemotherapy to reduce the risk of infection from febrile neutropenia. The injector delivers the medication in five minutes and includes a retractable needle for greater safety and comfort. With this approval, Coherus aims to provide a more convenient and user-friendly solution for managing chemotherapy side effects.

In June 2024, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Fusion Pharmaceuticals Inc. for $2.5 billion. This acquisition aims to strengthen AstraZeneca's oncology portfolio with advanced radiopharmaceuticals such as FPI-2265, enhance its research and development and manufacturing capabilities, and accelerate the transition toward targeted cancer therapies. It also deepens the company's presence in Canada. Fusion Pharmaceuticals, based in Canada, specializes in developing next-generation radiopharmaceuticals as precision treatments for oncology.

Major players in the radiation toxicity treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Amgen Inc., Varian Medical Systems, Recipharm AB, Elekta AB, Lantheus Medical Imaging Inc., Ion Beam Applications SA, Accuray Incorporated, Coherus BioSciences Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Theragenics Corp., NorthStar Medical Radioisotopes LLC, Fusion Pharmaceuticals Inc., Blue Earth Diagnostics Ltd., Partner Therapeutics Inc., Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, Humanetics Corporation, Actinium Pharmaceuticals Inc., and Clarity Pharmaceuticals Ltd.

North America was the largest region in the radiation toxicity treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiation toxicity treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiation toxicity treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiation toxicity treatment market includes revenues earned by entities by providing services such as blood transfusions, chelation therapy, skin care and burn management, cancer screening, pain management, and bone marrow protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation toxicity treatment market consists of sales of radiation detection and survey devices, personal dosimeters, linear accelerators (LINACs), and neutron capture therapy systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiation Toxicity Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiation toxicity treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiation toxicity treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiation toxicity treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Colony Stimulating Factors; Potassium Iodide; Prussian Blue; Diethylenetriamine Pentaacetic Acid; Others Products
• 2) By Indication: Acute Radiation Syndrome; Chronic Radiation Syndrome
• 3) By Radiation Type: Ionizing Radiation; Non-Ionizing Radiation
• 4) By End-User: Hospitals; Research And Academic Institutes
• Subsegments:
• 1) By Colony Stimulating Factors: Granulocyte Colony-Stimulating Factor (G-CSF); Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
• 2) By Potassium Iodide: Oral Potassium Iodide Tablets; Liquid Potassium Iodide Solution
• 3) By Prussian Blue: Capsules Of Prussian Blue; Prussian Blue Resin
• 4) By Diethylenetriamine Pentaacetic Acid (DTPA): DTPA Injection (Calcium And Zinc DTPA)
• 5) By Other Products: Amifostine; Sodium Bicarbonate; Doxycycline; Activated Charcoal
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiation Toxicity Treatment Market Characteristics

3. Radiation Toxicity Treatment Market Trends And Strategies

4. Radiation Toxicity Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Radiation Toxicity Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Radiation Toxicity Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Radiation Toxicity Treatment Market Growth Rate Analysis
• 5.4. Global Radiation Toxicity Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Radiation Toxicity Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Radiation Toxicity Treatment Total Addressable Market (TAM)

6. Radiation Toxicity Treatment Market Segmentation

• 6.1. Global Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Colony Stimulating Factors
• Potassium Iodide
• Prussian Blue
• Diethylenetriamine Pentaacetic Acid
• Others Products
• 6.2. Global Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Radiation Syndrome
• Chronic Radiation Syndrome
• 6.3. Global Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ionizing Radiation
• Non-Ionizing Radiation
• 6.4. Global Radiation Toxicity Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research And Academic Institutes
• 6.5. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Colony Stimulating Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Granulocyte Colony-Stimulating Factor (G-CSF)
• Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
• 6.6. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Potassium Iodide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Potassium Iodide Tablets
• Liquid Potassium Iodide Solution
• 6.7. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Prussian Blue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsules Of Prussian Blue
• Prussian Blue Resin
• 6.8. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Diethylenetriamine Pentaacetic Acid (DTPA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DTPA Injection (Calcium And Zinc DTPA)
• 6.9. Global Radiation Toxicity Treatment Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amifostine
• Sodium Bicarbonate
• Doxycycline
• Activated Charcoal

7. Radiation Toxicity Treatment Market Regional And Country Analysis

• 7.1. Global Radiation Toxicity Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Radiation Toxicity Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiation Toxicity Treatment Market

• 8.1. Asia-Pacific Radiation Toxicity Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiation Toxicity Treatment Market

• 9.1. China Radiation Toxicity Treatment Market Overview
• 9.2. China Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiation Toxicity Treatment Market

• 10.1. India Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiation Toxicity Treatment Market

• 11.1. Japan Radiation Toxicity Treatment Market Overview
• 11.2. Japan Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiation Toxicity Treatment Market

• 12.1. Australia Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiation Toxicity Treatment Market

• 13.1. Indonesia Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiation Toxicity Treatment Market

• 14.1. South Korea Radiation Toxicity Treatment Market Overview
• 14.2. South Korea Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiation Toxicity Treatment Market

• 15.1. Western Europe Radiation Toxicity Treatment Market Overview
• 15.2. Western Europe Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiation Toxicity Treatment Market

• 16.1. UK Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiation Toxicity Treatment Market

• 17.1. Germany Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiation Toxicity Treatment Market

• 18.1. France Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiation Toxicity Treatment Market

• 19.1. Italy Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiation Toxicity Treatment Market

• 20.1. Spain Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiation Toxicity Treatment Market

• 21.1. Eastern Europe Radiation Toxicity Treatment Market Overview
• 21.2. Eastern Europe Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiation Toxicity Treatment Market

• 22.1. Russia Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiation Toxicity Treatment Market

• 23.1. North America Radiation Toxicity Treatment Market Overview
• 23.2. North America Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiation Toxicity Treatment Market

• 24.1. USA Radiation Toxicity Treatment Market Overview
• 24.2. USA Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiation Toxicity Treatment Market

• 25.1. Canada Radiation Toxicity Treatment Market Overview
• 25.2. Canada Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiation Toxicity Treatment Market

• 26.1. South America Radiation Toxicity Treatment Market Overview
• 26.2. South America Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiation Toxicity Treatment Market

• 27.1. Brazil Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiation Toxicity Treatment Market

• 28.1. Middle East Radiation Toxicity Treatment Market Overview
• 28.2. Middle East Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiation Toxicity Treatment Market

• 29.1. Africa Radiation Toxicity Treatment Market Overview
• 29.2. Africa Radiation Toxicity Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Radiation Toxicity Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Radiation Toxicity Treatment Market, Segmentation By Radiation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiation Toxicity Treatment Market Competitive Landscape And Company Profiles

• 30.1. Radiation Toxicity Treatment Market Competitive Landscape
• 30.2. Radiation Toxicity Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Radiation Toxicity Treatment Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC
• 31.2. Novartis AG
• 31.3. Amgen Inc.
• 31.4. Varian Medical Systems
• 31.5. Recipharm AB
• 31.6. Elekta AB
• 31.7. Lantheus Medical Imaging Inc.
• 31.8. Ion Beam Applications SA
• 31.9. Accuray Incorporated
• 31.10. Coherus BioSciences Inc.
• 31.11. Eckert & Ziegler Strahlen- und Medizintechnik AG
• 31.12. Theragenics Corp.
• 31.13. NorthStar Medical Radioisotopes LLC
• 31.14. Fusion Pharmaceuticals Inc.
• 31.15. Blue Earth Diagnostics Ltd.

32. Global Radiation Toxicity Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiation Toxicity Treatment Market

34. Recent Developments In The Radiation Toxicity Treatment Market

35. Radiation Toxicity Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Radiation Toxicity Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Radiation Toxicity Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Radiation Toxicity Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료